What Are Biosimilars? – HealthyWomen
Biosimilars are alternatives to biologics that are just as effective and more affordable. Learn about these drugs and whether they could be an option for you.
What are biosimilars?
Biosimilars are copies of biologics, which are drugs made from natural sources like plant or human cells. They are used to treat various health conditions such as rheumatoid arthritis, psoriasis, Crohn’s disease, and cancer.
- Rheumatoid arthritis (RA)
- Psoriasis
- Crohn’s disease
- Various types of cancer
Biosimilars are safe and effective
Biosimilars are nearly identical to biologics and FDA-approved. They work the same way to treat many health problems, providing a safe and effective alternative.
Lower production costs = cheaper drugs
Biosimilars are more affordable than biologics due to lower production costs. Biologics for conditions like RA can cost up to $30,000 a year, making biosimilars a cost-effective option.
Picking possible candidates
Companies choose to develop biosimilars based on cost and efficacy factors compared to biologics.
Meeting FDA standards
Biosimilars must meet FDA standards for approval, ensuring they work the same way as the original biologic through rigorous testing and analysis.
Availability of biosimilars
44 biosimilars are FDA-approved in the U.S., including those modeled after drugs like adalimumab (Humira) used to treat autoimmune conditions.
Roadblocks to biosimilars
Although demand is growing, biosimilars face challenges with limited use in the U.S. due to opposition from biologic manufacturers and insurance coverage issues.
Helping people access treatment
Biosimilars provide an affordable option for patients who may struggle to access treatment, with an average cost savings of 30% compared to biologics.
Are biosimilars right for you?
Consult your healthcare provider about switching to biosimilars if you’re currently using a biologic. There may be a safer, equally effective option available at a lower cost.
This educational resource was created with support from Amgen, a HealthyWomen Corporate Advisory Council member.
